Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10-chloro-2,3,7,11b-tetrahydro-3-methyl-11b-(2-chlorophenyl)oxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one
2. Cs 386
3. Cs-386
1. Melex
2. 31868-18-5
3. Cs-386
4. Chebi:31842
5. S5969b6237
6. 10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one
7. 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyloxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one
8. Mexazolamum
9. Mexazolam [inn:jan]
10. Mexazolamum [inn-latin]
11. Cs 386
12. 10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,7,11b-tetrahydrobenzo[f]oxazolo[3,2-d][1,4]diazepin-6(5h)-one
13. Brn 1091849
14. Sedoxil
15. Unii-s5969b6237
16. Melex (tn)
17. Mexazolam (jan/inn)
18. Mexazolam [inn]
19. Mexazolam [jan]
20. Mexazolam [mi]
21. Mexazolam [mart.]
22. Mexazolam [who-dd]
23. Dsstox_cid_31504
24. Dsstox_rid_97389
25. Dsstox_gsid_57715
26. 10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
27. Schembl218453
28. Chembl1743261
29. Dtxsid9057715
30. Tox21_113740
31. Db15489
32. Ncgc00253606-01
33. Oxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one, 10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyl-
34. Cas-31868-18-5
35. D01316
36. Q6148446
| Molecular Weight | 363.2 g/mol |
|---|---|
| Molecular Formula | C18H16Cl2N2O2 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 362.0588831 g/mol |
| Monoisotopic Mass | 362.0588831 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 505 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Mexazolam is indicated for the treatment of anxiety with or without psychoneurotic conditions.
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BA - Benzodiazepine derivatives
N05BA25 - Mexazolam
Absorption
The active metabolite chloronordiazepam has a Tmax of 1-2h.
Route of Elimination
Mexazolam is mainly eliminated in the bile and feces, with <10% eliminated as metabolites in the urine. >50% of a dose of mexazolam is eliminated as the metabolite chloroxazepam.
Mexazolam is rapidly metabolized to the active metabolites chloronordiazepam and chloroxazepam.
Mexazolam follows a 2 compartment model with a first half life of 1.4h and a second half life of 76h.
Mexazolam is a benzodiazepine that binds to benzodiazepine-type receptors, inhibiting gamma-aminobutyric acid.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
We have 1 companies offering Mexazolam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
Market Place
